Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of heteroaryl-3-oxo-propanenitrile derivatives in treating clinical wherein myelopoiesis suppression occurs

Use of heteroaryl-3-oxo-propanenitrile derivatives in treating clinical wherein myelopoiesis suppression occurs

US Patent 5206258 · Granted Apr 27, 1993

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mobile terminal and hub apparatus for use in a video communication system2024
Mobile terminal and hub apparatus for use in a video communication system2021
Benzyloxy prodigiosine compounds2002
Benzyloxy prodigiosine compounds2002
Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compou2001
Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compou2001
Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compou2001
Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation2000
Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation2000
Pyrrolydenemethyl-derivatives and process for their preparation1997
Pyrrolydenemethyl-derivatives and process for their preparation1997
Pyrrolydenemethyl-derivatives and process for their preparation1997